TP53 and neoplasm: Experimental models have that Keap1 and P53 co‐inactivation elicits SCC development in airway basal stem cells, but not in respiratory epithelial cells [7], suggesting that the acquired tumor phenotype depends on the differentiation state of the ancestor mutant cell.